<strong>Research progress of poly (ADP-ribose) polymerase inhibitors’ roles in combined therapies for cancer treatment</strong>

doi:10.3781/j.issn.1000-7431.2022.2104-0224

PDF(2073 KB)

Tumor ›› 2022, Vol. 42 ›› Issue (09) : 646-657. DOI: 10.3781/j.issn.1000-7431.2022.2104-0224

Review

Research progress of poly (ADP-ribose) polymerase inhibitors’ roles in combined therapies for cancer treatment

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(09): 646-657 https://doi.org/10.3781/j.issn.1000-7431.2022.2104-0224

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2073 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2021-04-19	2022-09-08	2022-09-25
Issue Date
2022-09-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS